Episode Details

Hermès made a splashy statement with its latest results, outshining its luxury rivals, while Novo Nordisk’s popular weight-loss drug has been linked to a lowered risk of Alzheimer’s.

Today’s stories:

• Hermès Came Out On Top With Its Latest Results, Leaving Luxury Rivals In The Dust
• Novo Nordisk's Ozempic Drug Might Work Wonders For Mind As Well As Body

Try Finimize Premium